Status:
COMPLETED
Evaluation of the Use of Radiomics in 18F-FDOPA PET Examinations for the Characterization of Gliomas
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Study on the Use of Radiomics in Gliomas of Initial Disgnosis
Eligibility:
All Genders
Brief Summary
The evaluation of gliomas in imaging represents a real challenge today, at the initial diagnosis, for therapeutic planning or follow-up treatment of these lesions. There is an urgent need for non-inva...
Eligibility Criteria
Inclusion
- Patient having performed a PET/CT examination at 18F-FDOPA for his glioma in the nuclear medicine department of the CHRU de Brabois for which the raw data are available;
- Person who received full information on the organization of the research and did not object to the use of these data;
- Patients affiliated to a social security scheme
Exclusion
- \- Person who received full information on the organization of the research and who objected to the use of the data
- Adult person subject to a legal protection measure (guardianship, curatorship, safeguard of justice).
- A person of full age who is unable to give consent and who is not subject to a legal protection measure.
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 20 2020
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04469244
Start Date
July 1 2020
End Date
October 20 2020
Last Update
August 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU of Nancy
Vandœuvre-lès-Nancy, France, 54511